Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is 1 of the champion performing pharma stocks successful 2025. Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) announced connected January 8 the enactment of AMX0318 arsenic a improvement campaigner for post-bariatric hypoglycemia (PBH) and different uncommon diseases. AMX0318 is simply a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist and was identified done a probe collaboration with Gubra A/S. Gubra A/S is progressive successful peptide-based cause find and preclinical declaration probe services.

Camille L. Bedrosian, MD, Chief Medical Officer astatine Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), stated that AMX0318 has exhibited robust preclinical and chemic properties, including “a pharmacokinetic illustration that whitethorn enactment long-acting administration.”

Management further demonstrated beardown condemnation that inhibiting GLP-1 receptor enactment marks a important therapeutic approach, provided the statistically important information that avexitide, its investigational, first-in-class GLP-1 receptor antagonist, has generated to date. Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) expects the completion of recruitment successful its pivotal Phase 3 LUCIDITY proceedings of avexitide by Q1 2026, with topline information expected successful Q3 2026.

AMX0318 has completed an elaborate preclinical evaluation, and the institution anticipates the programme to beforehand into investigational caller cause (IND)-enabling studies aboriginal this year. An IND is targeted for 2027, fixed the pending palmy completion of IND-enabling studies.

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) provides therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). The company’s commercialized merchandise is Relyvrio, which is besides known arsenic Albrioza successful Canada.

While we admit the imaginable of AMLX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.